Conferences & Events News
6th Annual Achieving Quality & Process Excellence in the Pharmaceutical Industry
15-17 September 2010, Lisbon, Portugal.What are the best practices to achieve QC Laboratory Excellence? How successful are you in adopting and sustaining consistent, harmonized & compliant quality systems?
The Brussels Pharmaceuticals Conference 2010
The Brussels Pharmaceuticals Conference will be held on the 5th May 2010. This high-level event will provide a unique opportunity for key stakeholders to discuss the current developments in European pharmaceutical policy.
Last Call for Med-e-Tel 2010 Early Bird Registration
The Med-e-Tel forum is the ideal opportunity to follow up on the latest developments and initiatives in Telemedicine and eHealth and to exchange ideas and experiences related to ICT applications in healthcare. Register on or before Monday, 15th March, 2010 and get the early bird rate for your Med-e-Tel registration.
Final Line-Up for the Inaugural Health 2.0 Conference in Europe
Health 2.0 Europe will take place at the Cité Internationale Universitaire in Paris. This event will feature the three integral components of Health 2.0 in a rapid-fire live demo format where leading examples of Health 2.0 in North America will be compared and contextualized with the latest in European innovation.
Web Innovators, Pharma, Insurance and Government Converge to Speak at Health 2.0 Europe
Health 2.0 Europe, a conference dedicated to how Web 2.0 and social media are transforming healthcare systems in Europe, has finalized its agenda and speaker list. Encompassing all aspects of the healthcare chain, the interactive program will address healthcare on both country- and European-wide levels, with local experts from converging industries.
Final agenda and Sponsorship deadline for Health 2.0 Europe
More Pharma News ...
Business & Industry
- Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
- CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
- Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
- BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
- Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
Research & Development
- Candidate found to inhibit malignant melanoma growth
- A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
- 'Biohybrid' device could restore function in paralysed limbs
- Scientists use tardigrade proteins for human health breakthrough
- DNA treatment could delay paralysis that strikes nearly all patients with ALS
- Scientists reveal a potential new approach to treating liver cancer
- Normalizing tumor blood vessels may improve immunotherapy against brain cancer
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA approves first over-the-counter naloxone nasal spray
- FDA grants Accelerated Approval for Alzheimer's disease treatment
- FDA approves new HIV drug for adults with limited treatment options
- FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
- FDA approves first gene therapy to treat adults with Hemophilia B